Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$62.09 - $86.14 $2.45 Million - $3.4 Million
-39,515 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$52.92 - $81.17 $832,590 - $1.28 Million
15,733 Added 66.16%
39,515 $3.21 Million
Q4 2018

Feb 13, 2019

BUY
$43.37 - $59.54 $1.03 Million - $1.42 Million
23,782 New
23,782 $1.29 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.